<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">It is evident from the literature that convalescent plasma from recovered patients can be administered to patients as a medication (
 <xref rid="bib20" ref-type="bibr">Cheng et al., 2005</xref>; 
 <xref rid="bib87" ref-type="bibr">Mair-Jenkins et al., 2015</xref>). In 2003, a case study was done at Taiwan hospital, during the SARS outbreak, convalescent plasma (500Â ml) free of residual SARS-CoV confirmed by RT-PCR was collected from three SARS patients and transfused into the three infected healthcare workers. Viral load decreased rapidly one day after transfusion, and all the patients survived (
 <xref rid="bib158" ref-type="bibr">Yeh et al., 2005</xref>). In 2014, the WHO also proposed using convalescent plasma obtained from recovered Ebola patients during outbreaks as an effective treatment (
 <xref rid="bib107" ref-type="bibr">Organization, 2014</xref>).
</p>
